首页 > 最新文献

Medicina intensiva最新文献

英文 中文
Toward transparent clinical decision support in the ICU: A multi-window, model-agnostic explainability approach for 72-h mortality prediction using the eICU collaborative research database. ICU的透明临床决策支持:使用eICU合作研究数据库进行72小时死亡率预测的多窗口、模型不可知的可解释性方法。
Pub Date : 2025-11-03 DOI: 10.1016/j.medine.2025.502349
Daniel Gallardo Gómez, Sara Díaz, Javier Quintero Sosa, Claudia Jiménez Vázquez, Álvaro Ritoré-Hidalgo, Antonio Gutiérrez-Pizarraya, Miguel Ángel Armengol de la Hoz, María Recuerda Núñez, Ángel Estella

Objective: This study has two main objectives: (1) to develop a multi-model framework for predicting Intensive Care Unit (ICU) mortality within the first 72 h of admission; and (2) to introduce a novel model-agnostic explainability approach classification that enables variable-level interpretation of predicted probabilities.

Design: Retrospective study using a multi-model machine learning approach, analyzing data across multiple time windows and incorporating demographic, clinical, and biochemical variables.

Setting: ICU mortality.

Patients or participants: Patients included in the eICU database over 16 years old who have been admitted to ICUs in 2014 and 2015 with available data within the first 72 h after ICU admission. A total of 106,449 patients were included in the analyses.

Interventions: No clinical interventions were applied; this was a retrospective analysis for predictive model development and evaluation.

Main variables of interest: Demographic, clinical, and biochemical variables collected across multiple time windows.

Results: A total of 106,449 were included (mean age 62.6 years, 46% women), with an overall 72-h mortality of 4.8%. Random Forest models achieved one of the best results in terms of predictive performance metrics, with F1-scores of 0.93, 95% CI 0.93 to 0.94; 0.92, 95% CI 0.92 to 0.93 and 0.83, 95% CI 0.83 to 0.85 across the three temporal data windows. Due to these metrics, the ability to predict deaths, and the biological plausibility of the predictions, Random Forest models were selected from all those studied.

Conclusions: The proposed multi-model approach significantly improves 72-h ICU mortality prediction. Moreover, we outline a model-agnostic strategy for variable-level interpretation of predicted probabilities, which may facilitate transparency and support future applications in clinical decision support.

目的:本研究有两个主要目的:(1)建立一个多模型框架来预测重症监护室(ICU)入院后72 小时内的死亡率;(2)引入一种新的模型不可知的可解释性分类方法,使预测概率的变量水平解释成为可能。设计:采用多模型机器学习方法进行回顾性研究,分析跨多个时间窗口的数据,并结合人口统计学、临床和生化变量。设置:ICU死亡率。患者或参与者:纳入eICU数据库的患者,年龄大于16岁,于2014年和2015年入住ICU,并在ICU入住后的前72 h内可获得数据 。共有106,449名患者被纳入分析。干预措施:未采用临床干预措施;这是对预测模型开发和评估的回顾性分析。感兴趣的主要变量:在多个时间窗口收集的人口统计学、临床和生化变量。结果:共纳入106,449例(平均年龄62.6岁,46%为女性),72小时总死亡率为4.8%。随机森林模型在预测性能指标方面取得了最好的结果之一,f1得分为0.93,95% CI为0.93至0.94;0.92, 95% CI 0.92 ~ 0.93和0.83,95% CI 0.83 ~ 0.85,跨越三个时间数据窗口。由于这些指标,预测死亡的能力,以及预测的生物学合理性,随机森林模型从所有研究中选择。结论:提出的多模型方法可显著提高ICU 72 h死亡率预测。此外,我们概述了一种模型不可知策略,用于预测概率的可变水平解释,这可能促进透明度并支持未来在临床决策支持中的应用。
{"title":"Toward transparent clinical decision support in the ICU: A multi-window, model-agnostic explainability approach for 72-h mortality prediction using the eICU collaborative research database.","authors":"Daniel Gallardo Gómez, Sara Díaz, Javier Quintero Sosa, Claudia Jiménez Vázquez, Álvaro Ritoré-Hidalgo, Antonio Gutiérrez-Pizarraya, Miguel Ángel Armengol de la Hoz, María Recuerda Núñez, Ángel Estella","doi":"10.1016/j.medine.2025.502349","DOIUrl":"https://doi.org/10.1016/j.medine.2025.502349","url":null,"abstract":"<p><strong>Objective: </strong>This study has two main objectives: (1) to develop a multi-model framework for predicting Intensive Care Unit (ICU) mortality within the first 72 h of admission; and (2) to introduce a novel model-agnostic explainability approach classification that enables variable-level interpretation of predicted probabilities.</p><p><strong>Design: </strong>Retrospective study using a multi-model machine learning approach, analyzing data across multiple time windows and incorporating demographic, clinical, and biochemical variables.</p><p><strong>Setting: </strong>ICU mortality.</p><p><strong>Patients or participants: </strong>Patients included in the eICU database over 16 years old who have been admitted to ICUs in 2014 and 2015 with available data within the first 72 h after ICU admission. A total of 106,449 patients were included in the analyses.</p><p><strong>Interventions: </strong>No clinical interventions were applied; this was a retrospective analysis for predictive model development and evaluation.</p><p><strong>Main variables of interest: </strong>Demographic, clinical, and biochemical variables collected across multiple time windows.</p><p><strong>Results: </strong>A total of 106,449 were included (mean age 62.6 years, 46% women), with an overall 72-h mortality of 4.8%. Random Forest models achieved one of the best results in terms of predictive performance metrics, with F1-scores of 0.93, 95% CI 0.93 to 0.94; 0.92, 95% CI 0.92 to 0.93 and 0.83, 95% CI 0.83 to 0.85 across the three temporal data windows. Due to these metrics, the ability to predict deaths, and the biological plausibility of the predictions, Random Forest models were selected from all those studied.</p><p><strong>Conclusions: </strong>The proposed multi-model approach significantly improves 72-h ICU mortality prediction. Moreover, we outline a model-agnostic strategy for variable-level interpretation of predicted probabilities, which may facilitate transparency and support future applications in clinical decision support.</p>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":" ","pages":"502349"},"PeriodicalIF":0.0,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145440330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
β-lactam antibiotics to prevent ventilator-associated pneumonia (VAP) in coma patients: A systematic review and meta-analysis of randomized controlled trials β-内酰胺抗生素预防昏迷患者呼吸机相关性肺炎(VAP):随机对照试验的系统回顾和荟萃分析
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502199
Edinson Dante Meregildo-Rodriguez , Mariano Ortiz-Pizarro , Martha Genara Asmat-Rubio , Carlos Geraldo Fernandez-Narváez , Gustavo Adolfo Vásquez-Tirado

Objective

To evaluate the effect of parenteral β-lactam antibiotics on outcomes related to ventilator-associated pneumonia (VAP) in adult patients in coma due to acute brain injury (ABI).

Design

Systematic review and meta-analysis.

Setting

Randomized controlled trials (RCTs) published up toSeptember 30, 2024.

Patients or participants

Adult patients in coma due to ABI.

Interventions

Parenteral β-lactam antibiotics.

Main variables of interest

Incidence and outcomes related to VAP.

Results

Three RCTs involving 483 patients met inclusion criteria; 231 patients received β-lactam prophylaxis. Among these, there were 115 cases of early-onset VAP (EO-VAP), 49 of late-onset VAP (LO-VAP), and 102 deaths. All studies were conducted in Europe. Causes of coma included trauma, stroke, and CO poisoning. Intravenous β-lactams (ampicillin/sulbactam, cefuroxime, and ceftriaxone) reduced EO-VAP risk by 57% (RR 0.43; 95% CI 0.30–0.61), and all-VAP by 35% (RR 0.65; 95% CI 0.53–0.80).
No impact was observed on LO-VAP (RR 0.95; 95% CI 0.54–1.67), 28-day mortality (RR 0.76; 95% CI 0.53–1.09), intubation duration (SMD -0.13; 95% CI −0.46–0.21), or ICU length of stay (SMD −0.22; 95% CI −0.55–0.12). Heterogeneity and the risk of bias were low, with high overall evidence certainty.

Conclusions

In adult patients in coma due to ABI, intravenous β-lactam antibiotics reduce EO-VAP and all-VAP risk.
目的:探讨β-内酰胺类抗生素对成人急性脑损伤(ABI)昏迷患者呼吸机相关性肺炎(VAP)预后的影响。设计:系统回顾和荟萃分析。环境:随机对照试验(rct),截止到2024年9月30日。患者或参与者:因ABI而昏迷的成年患者。干预措施:肠外β-内酰胺类抗生素。主要感兴趣的变量:与VAP相关的发病率和预后。结果:3项rct共纳入483例患者,符合纳入标准;231例患者接受β-内酰胺预防治疗。早发型VAP 115例(EO-VAP),晚发型VAP 49例(LO-VAP),死亡102例。所有的研究都在欧洲进行。昏迷的原因包括外伤、中风和一氧化碳中毒。静脉注射β-内酰胺类药物(氨苄西林/舒巴坦、头孢呋辛和头孢曲松)可降低57%的EO-VAP风险(RR 0.43;95% CI 0.30-0.61), all-VAP降低35% (RR 0.65;95% ci 0.53-0.80)。对LO-VAP无影响(RR 0.95;95% CI 0.54-1.67), 28天死亡率(RR 0.76;95% CI 0.53-1.09)、插管时间(SMD -0.13;95% CI -0.46-0.21)或ICU住院时间(SMD -0.22;95% ci -0.55-0.12)。异质性和偏倚风险较低,总体证据确定性较高。结论:在ABI致昏迷的成人患者中,静脉注射β-内酰胺类抗生素可降低EO-VAP和all-VAP的风险。
{"title":"β-lactam antibiotics to prevent ventilator-associated pneumonia (VAP) in coma patients: A systematic review and meta-analysis of randomized controlled trials","authors":"Edinson Dante Meregildo-Rodriguez ,&nbsp;Mariano Ortiz-Pizarro ,&nbsp;Martha Genara Asmat-Rubio ,&nbsp;Carlos Geraldo Fernandez-Narváez ,&nbsp;Gustavo Adolfo Vásquez-Tirado","doi":"10.1016/j.medine.2025.502199","DOIUrl":"10.1016/j.medine.2025.502199","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effect of parenteral β-lactam antibiotics on outcomes related to ventilator-associated pneumonia (VAP) in adult patients in coma due to acute brain injury (ABI).</div></div><div><h3>Design</h3><div>Systematic review and meta-analysis.</div></div><div><h3>Setting</h3><div>Randomized controlled trials (RCTs) published up toSeptember 30, 2024.</div></div><div><h3>Patients or participants</h3><div>Adult patients in coma due to ABI.</div></div><div><h3>Interventions</h3><div>Parenteral β-lactam antibiotics.</div></div><div><h3>Main variables of interest</h3><div>Incidence and outcomes related to VAP.</div></div><div><h3>Results</h3><div><span>Three RCTs involving 483 patients met inclusion criteria; 231 patients received β-lactam prophylaxis. Among these, there were 115 cases of early-onset VAP (EO-VAP), 49 of late-onset VAP (LO-VAP), and 102 deaths. All studies were conducted in Europe. Causes of coma included trauma, stroke, and CO poisoning. Intravenous β-lactams (ampicillin/sulbactam, </span>cefuroxime, and ceftriaxone) reduced EO-VAP risk by 57% (RR 0.43; 95% CI 0.30–0.61), and all-VAP by 35% (RR 0.65; 95% CI 0.53–0.80).</div><div>No impact was observed on LO-VAP (RR 0.95; 95% CI 0.54–1.67), 28-day mortality (RR 0.76; 95% CI 0.53–1.09), intubation<span> duration (SMD -0.13; 95% CI −0.46–0.21), or ICU length of stay (SMD −0.22; 95% CI −0.55–0.12). Heterogeneity and the risk of bias were low, with high overall evidence certainty.</span></div></div><div><h3>Conclusions</h3><div>In adult patients in coma due to ABI, intravenous β-lactam antibiotics reduce EO-VAP and all-VAP risk.</div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502199"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143723048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in extracorporeal liver support for acute and acute-on-chronic liver failure 体外肝支持治疗急性和急性伴慢性肝衰竭的研究进展。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502291
David Toapanta-Gaibor , Jesús Sánchez-Ballesteros , María González-Fernández , María Jesús Broch-Porcar
Liver failure, either acute (ALF) or acute-on-chronic (ACLF), is characterized by hepatocellular dysfunction, systemic inflammation, and multiorgan failure, leading to high mortality without liver transplantation (LT). However, LT is limited by organ shortages and medical contraindications, necessitating alternative therapeutic strategies.
Biological liver support systems, incorporate functional hepatocytes to partially restore hepatic metabolic functions, though clinical trials have not demonstrated a survival benefit. Artificial systems, such as albumin dialysis (MARS, Prometheus), facilitate toxin removal, though evidence remains limited.
Continuous renal replacement therapy, while not specific for liver failure, is essential in patients with severe hyperammonemia or acute kidney injury, aiding in ammonia clearance and fluid balance control.
Plasma exchange (PE) has promising detoxification and immunomodulatory effects, improving survival in ALF. In ACLF, PE may reduce systemic inflammation, though evidence remains limited.
Further studies are needed to optimize ECLS therapies, refine patient selection, and establish their role in ALF and ACLF management.
急性(ALF)或急性伴慢性(ACLF)肝衰竭的特点是肝细胞功能障碍、全身炎症和多器官功能衰竭,导致不进行肝移植(LT)的高死亡率。然而,肝移植受到器官短缺和医学禁忌症的限制,需要其他治疗策略。生物肝支持系统包含功能性肝细胞,可部分恢复肝脏代谢功能,但临床试验尚未证明其对生存有好处。人工系统,如白蛋白透析(MARS,普罗米修斯),有助于毒素的清除,尽管证据仍然有限。持续的肾脏替代治疗,虽然不是针对肝功能衰竭,但对于严重高氨血症或急性肾损伤的患者是必不可少的,有助于氨清除和液体平衡控制。血浆交换(PE)具有良好的解毒和免疫调节作用,可提高ALF患者的生存率。在ACLF中,PE可能减轻全身性炎症,尽管证据仍然有限。需要进一步的研究来优化ECLS疗法,优化患者选择,并确定其在ALF和ACLF管理中的作用。
{"title":"Advances in extracorporeal liver support for acute and acute-on-chronic liver failure","authors":"David Toapanta-Gaibor ,&nbsp;Jesús Sánchez-Ballesteros ,&nbsp;María González-Fernández ,&nbsp;María Jesús Broch-Porcar","doi":"10.1016/j.medine.2025.502291","DOIUrl":"10.1016/j.medine.2025.502291","url":null,"abstract":"<div><div>Liver failure, either acute (ALF) or acute-on-chronic (ACLF), is characterized by hepatocellular dysfunction, systemic inflammation, and multiorgan failure, leading to high mortality without liver transplantation (LT). However, LT is limited by organ shortages and medical contraindications, necessitating alternative therapeutic strategies.</div><div>Biological liver support systems, incorporate functional hepatocytes to partially restore hepatic metabolic functions, though clinical trials have not demonstrated a survival benefit. Artificial systems, such as albumin dialysis (MARS, Prometheus), facilitate toxin removal, though evidence remains limited.</div><div>Continuous renal replacement therapy, while not specific for liver failure, is essential in patients with severe hyperammonemia or acute kidney injury, aiding in ammonia clearance and fluid balance control.</div><div>Plasma exchange (PE) has promising detoxification and immunomodulatory effects, improving survival in ALF. In ACLF, PE may reduce systemic inflammation, though evidence remains limited.</div><div>Further studies are needed to optimize ECLS therapies, refine patient selection, and establish their role in ALF and ACLF management.</div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502291"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144839534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive Care Departments organization towards High-Quality Care: SOGAMIUC recommendations Using a Delphi Methodology (endorsed by SEMICYUC, SAMI, SBMICIUC, SOCAMICYUC, SNMIUC, SCLMICYUC, SOCMIC, SEXMICYUC, and SOMIUC) 重症监护室向高质量护理组织:SOGAMIUC建议使用德尔菲方法(由semiyuc, SAMI, SBMICIUC, SOCAMICYUC, SNMIUC, SCLMICYUC, SOCMIC, SEXMICYUC和SOMIUC认可)。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502267
Pablo Vidal-Cortés , Rocío Gómez-López , Emilio Rodríguez-Ruiz , Paula Fernández-Ugidos , Fernando Eiras Abalde , Lorena del Río-Carbajo , Jorge Nieto-del Olmo , Daniel Ernesto Suárez Fernández , Ana María Ferreiro González , Mónica Mourelo Fariña , Pedro Rascado Sedes , María José de la Torre Fernández , José Luis Martínez Melgar , Miguel Ángel Fernández López , María José Castro Orjales , Patricia Barral Segade , Víctor José López Ciudad , María Isabel Álvarez Diéguez , Salvador Fojón Polanco
The proper organization of Intensive Care Medicine Departments is a key element in order to ensure high-quality care of critically ill patients and to preserve the well-being of healthcare professionals. Using a Delphi methodology, the Galician Society of Intensive Care Medicine and Coronary Units (SOGAMIUC) has reached a consensus on a set of recommendations covering structure, clinical organization, continuous care, specialized programs, and staffing requirements in ICUs. These recommendations aim to optimize continuity of care and patient safety, promote a healthy work environment, and encourage the development of advanced clinical programs. Implementation of these measures is proposed as an essential step toward improving clinical outcomes and the well-being of healthcare professionals in Intensive Care Departments.
重症监护室的适当组织是确保重症患者高质量护理和维护医疗保健专业人员健康的关键因素。加利西亚重症监护医学和冠状动脉病房协会(SOGAMIUC)采用德尔菲方法,就icu的结构、临床组织、持续护理、专业项目和人员配备要求等一系列建议达成了共识。这些建议旨在优化护理的连续性和患者安全,促进健康的工作环境,并鼓励发展先进的临床方案。这些措施的实施被认为是改善临床结果和重症监护室医护人员福祉的重要一步。
{"title":"Intensive Care Departments organization towards High-Quality Care: SOGAMIUC recommendations Using a Delphi Methodology (endorsed by SEMICYUC, SAMI, SBMICIUC, SOCAMICYUC, SNMIUC, SCLMICYUC, SOCMIC, SEXMICYUC, and SOMIUC)","authors":"Pablo Vidal-Cortés ,&nbsp;Rocío Gómez-López ,&nbsp;Emilio Rodríguez-Ruiz ,&nbsp;Paula Fernández-Ugidos ,&nbsp;Fernando Eiras Abalde ,&nbsp;Lorena del Río-Carbajo ,&nbsp;Jorge Nieto-del Olmo ,&nbsp;Daniel Ernesto Suárez Fernández ,&nbsp;Ana María Ferreiro González ,&nbsp;Mónica Mourelo Fariña ,&nbsp;Pedro Rascado Sedes ,&nbsp;María José de la Torre Fernández ,&nbsp;José Luis Martínez Melgar ,&nbsp;Miguel Ángel Fernández López ,&nbsp;María José Castro Orjales ,&nbsp;Patricia Barral Segade ,&nbsp;Víctor José López Ciudad ,&nbsp;María Isabel Álvarez Diéguez ,&nbsp;Salvador Fojón Polanco","doi":"10.1016/j.medine.2025.502267","DOIUrl":"10.1016/j.medine.2025.502267","url":null,"abstract":"<div><div>The proper organization of Intensive Care Medicine Departments is a key element in order to ensure high-quality care of critically ill patients and to preserve the well-being of healthcare professionals. Using a Delphi methodology, the Galician Society of Intensive Care Medicine and Coronary Units (SOGAMIUC) has reached a consensus on a set of recommendations covering structure, clinical organization, continuous care, specialized programs, and staffing requirements in ICUs. These recommendations aim to optimize continuity of care and patient safety, promote a healthy work environment, and encourage the development of advanced clinical programs. Implementation of these measures is proposed as an essential step toward improving clinical outcomes and the well-being of healthcare professionals in Intensive Care Departments.</div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502267"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiogenic shock due to a large apical pseudoaneurysm of the left ventricle: A rare complication 心源性休克由于一个大的顶端假性动脉瘤的左心室:一个罕见的并发症。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502212
Jaime Andrés Romero León, Elena Morente García, Eva Peregrina Caño
{"title":"Cardiogenic shock due to a large apical pseudoaneurysm of the left ventricle: A rare complication","authors":"Jaime Andrés Romero León,&nbsp;Elena Morente García,&nbsp;Eva Peregrina Caño","doi":"10.1016/j.medine.2025.502212","DOIUrl":"10.1016/j.medine.2025.502212","url":null,"abstract":"","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502212"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analgesia, sedation, and neuromuscular blocking agents: A standardized protocol of analgosedation in COVID-19 镇痛、镇静和神经肌肉阻滞剂:新冠肺炎患者镇痛镇静的标准化方案
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502223
Cecilia Inés Loudet , Marisol García Sarubbio , María Julia Meschini , Jacqueline Vilca Becerra , María Agustina Mazzoleni , Vanesa Aramendi , Agustina Barbieri , Carolina Colavita , Gustavo Cerri , Sofía Pacho , Eliseo Hernán Ferrari , Rosa Reina

Objectives

Primary: To evaluate the level of sedation, use, daily doses, and duration of analgosedative drugs in COVID-19 patients on mechanical ventilation (MV) using a standardized protocol, comparing survivors and non-survivors. Secondary: To identify independent predictors of hospital mortality.

Design

Retrospective cohort study.

Setting

Medical-surgical ICU.

Patients

Adults with SARS-CoV-2 infection requiring invasive MV and continuous infusion of analgosedation and/or neuromuscular blocking agents (NMBAs) for at least 48 h.

Interventions

None.

Main variables of interest

Level of sedation, use, daily doses, and duration of analgosedative drugs; hospital mortality and associated factors.

Results

Among 198 patients (nurse-to-patient ratio 1:2.4; 65% staff turnover), median global RASS was –4.5. Kaplan–Meier analysis showed lower survival with deeper sedation. Fentanyl (99%) and midazolam (97%) were the most used, followed by NMBAs (81%), propofol and dexmedetomidine (48%). Non-benzodiazepine sedatives were precribed more in survivors (88%) than non-survivors (53%) (p < 0.01). Survivors had more days of fentanyl, midazolam, and dexmedetomidine; no differences in NMBA use or drug doses were observed. Mortality was 63%. Independent predictors of mortality included APACHE II, SOFA24, Charlson score, median RASS, and non-benzodiazepine sedative use.

Conclusions

Standardized protocols emphasizing the ACD components of the ABCDEF bundle, along with appropriate use of analgosedation and NMBAs despite limited staffing, effectively supported the management of sedation without significant dose differences between survivors and non-survivors. Sedation level and the use of non-benzodiazepine sedatives were independently associated with better outcomes, highlighting the importance of the light sedation and the ABCDEF bundle.
目的:主要:评估采用标准化方案机械通气(MV)的COVID-19患者镇静水平、使用、每日剂量和镇静药物持续时间,比较幸存者和非幸存者。次要目的:确定医院死亡率的独立预测因子。设计:回顾性队列研究。环境:内科-外科ICU。患者:成人SARS-CoV-2感染,需要侵入性MV和持续输注镇痛和/或神经肌肉阻断剂(nmba)至少48 h。干预措施:没有。感兴趣的主要变量:镇静水平、使用、每日剂量、镇痛药持续时间;医院死亡率及其相关因素。结果:198例患者中(护患比1:24 .4;65%的员工离职率),全球RASS中值为-4.5。Kaplan-Meier分析显示,镇静程度越深,生存率越低。使用最多的是芬太尼(99%)和咪达唑仑(97%),其次是nmba(81%)、异丙酚和右美托咪定(48%)。幸存者(88%)比非幸存者(53%)使用非苯二氮卓类镇静剂(p )24,Charlson评分、中位RASS和非苯二氮卓类镇静剂的使用。结论:标准化方案强调ABCDEF束的ACD成分,以及在人员有限的情况下适当使用镇静和NMBAs,有效地支持镇静管理,在幸存者和非幸存者之间没有显着的剂量差异。镇静水平和非苯二氮卓类镇静剂的使用与更好的结果独立相关,突出了轻度镇静和ABCDEF束的重要性。
{"title":"Analgesia, sedation, and neuromuscular blocking agents: A standardized protocol of analgosedation in COVID-19","authors":"Cecilia Inés Loudet ,&nbsp;Marisol García Sarubbio ,&nbsp;María Julia Meschini ,&nbsp;Jacqueline Vilca Becerra ,&nbsp;María Agustina Mazzoleni ,&nbsp;Vanesa Aramendi ,&nbsp;Agustina Barbieri ,&nbsp;Carolina Colavita ,&nbsp;Gustavo Cerri ,&nbsp;Sofía Pacho ,&nbsp;Eliseo Hernán Ferrari ,&nbsp;Rosa Reina","doi":"10.1016/j.medine.2025.502223","DOIUrl":"10.1016/j.medine.2025.502223","url":null,"abstract":"<div><h3>Objectives</h3><div>Primary: To evaluate the level of sedation, use, daily doses, and duration of analgosedative drugs in COVID-19 patients on mechanical ventilation (MV) using a standardized protocol, comparing survivors and non-survivors. Secondary: To identify independent predictors of hospital mortality.</div></div><div><h3>Design</h3><div>Retrospective cohort study.</div></div><div><h3>Setting</h3><div>Medical-surgical ICU.</div></div><div><h3>Patients</h3><div>Adults with SARS-CoV-2 infection requiring invasive MV and continuous infusion of analgosedation and/or neuromuscular blocking agents (NMBAs) for at least 48 h.</div></div><div><h3>Interventions</h3><div>None.</div></div><div><h3>Main variables of interest</h3><div>Level of sedation, use, daily doses, and duration of analgosedative drugs; hospital mortality and associated factors.</div></div><div><h3>Results</h3><div><span><span><span><span>Among 198 patients (nurse-to-patient ratio 1:2.4; 65% staff turnover), median global RASS was –4.5. Kaplan–Meier analysis showed lower survival with </span>deeper sedation. </span>Fentanyl<span> (99%) and midazolam (97%) were the most used, followed by NMBAs (81%), propofol and </span></span>dexmedetomidine<span> (48%). Non-benzodiazepine sedatives were precribed more in survivors (88%) than non-survivors (53%) (p &lt; 0.01). Survivors had more days of fentanyl, midazolam, and dexmedetomidine; no differences in NMBA use or drug doses were observed. Mortality was 63%. Independent predictors of mortality included APACHE II, SOFA</span></span><sub>24</sub><span>, Charlson score, median RASS, and non-benzodiazepine sedative use.</span></div></div><div><h3>Conclusions</h3><div>Standardized protocols emphasizing the ACD components of the ABCDEF bundle, along with appropriate use of analgosedation and NMBAs despite limited staffing, effectively supported the management of sedation without significant dose differences between survivors and non-survivors. Sedation level and the use of non-benzodiazepine sedatives were independently associated with better outcomes, highlighting the importance of the light sedation and the ABCDEF bundle.</div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502223"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144228012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of functional brain damage using resting-state functional magnetic resonance imaging in patients with diffuse axonal injury admitted to the ICU 静息状态功能磁共振成像对ICU弥漫性轴索损伤患者功能性脑损伤的评价。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502260
Patricia Serrats-López , Juan Antonio Llompart-Pou , Ana María González-Roldán , Juan Lorenzo Terrasa-Navarro , Apolonia Moll-Servera , Jon Pérez-Bárcena
{"title":"Evaluation of functional brain damage using resting-state functional magnetic resonance imaging in patients with diffuse axonal injury admitted to the ICU","authors":"Patricia Serrats-López ,&nbsp;Juan Antonio Llompart-Pou ,&nbsp;Ana María González-Roldán ,&nbsp;Juan Lorenzo Terrasa-Navarro ,&nbsp;Apolonia Moll-Servera ,&nbsp;Jon Pérez-Bárcena","doi":"10.1016/j.medine.2025.502260","DOIUrl":"10.1016/j.medine.2025.502260","url":null,"abstract":"","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502260"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144746665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short- and long-term mortality in critically ill patients with solid cancer. The Vall d’Hebron Intensive Care Unit-Vall d’Hebron Institute of Oncology Cohort: a retrospective study 实体癌危重病人的短期和长期死亡率。Vall d'Hebron重症监护病房-Vall d'Hebron肿瘤研究所队列:回顾性研究。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502176
Cándido Díaz-Lagares , Alejandra García-Roche , Andrés Pacheco , Javier Ros , Erika P. Plata-Menchaca , Adaia Albasanz , David Pérez , Nadia Saoudi , Isabel Ruiz-Camps , Elena Élez , Ricard Ferrer

Objective

To describe in-hospital and one-year mortality and to identify prognostic variables associated with mortality.

Design

Retrospective cohort study.

Setting

Tertiary referral hospital in Barcelona (Spain).

Patients

Consecutive patients with solid cancer and unplanned admission to the ICU over a ten year period (2010–2019).

Main variables of interest

In-hospital mortality, one-year mortality, type of cancer, metastatic disease, ECOG, APACHE, SOFA, invasive mechanical ventilation, vasoactive drugs, renal replacement therapy.

Results

Three hundred and ninety-five patients were admitted to the ICU; 193 (48.8%) had metastatic disease, and 22 (5.9%) presented neutropenia. The median SOFA score on day 1 of ICU admission was 6 (3−9). ICU, in-hospital, and one-year mortality were 27.9% (110 patients), 39% (139 patients), and 61.1% (236 patients), respectively. A non-surgical admission, a higher ECOG, a SOFA score > 9 on day 1, a non-decreasing SOFA score on day 5, and requiring invasive mechanical ventilation were factors associated with in-hospital mortality. ECOG, inability to resume anticancer therapy, and ICU admission due to respiratory failure were associated with one-year mortality in hospital survivors.

Conclusion

Survival in critically ill solid cancer patients is substantial, even when metastatic disease exists. Short-term outcomes were associated with ECOG and organ dysfunction, not cancer per se. The prognosis of patients with a non-decreasing SOFA score on day 5 is poor, especially when the SOFA score on day 1 was >9. Long-term mortality was associated with functional status and inability to resume anticancer therapy.
目的:描述住院和一年内死亡率,并确定与死亡率相关的预后变量。设计:回顾性队列研究。环境:巴塞罗那三级转诊医院(西班牙)。患者:连续10年(2010-2019年)非计划入住ICU的实体癌患者。主要感兴趣的变量:住院死亡率、一年死亡率、癌症类型、转移性疾病、ECOG、APACHE、SOFA、有创机械通气、血管活性药物、肾脏替代治疗。结果:395例患者入住ICU;193例(48.8%)有转移性疾病,22例(5.9%)出现中性粒细胞减少。入住ICU第1天SOFA评分中位数为6(3-9)。ICU、住院和1年死亡率分别为27.9%(110例)、39%(139例)和61.1%(236例)。非手术入院、较高的ECOG、第1天SOFA评分bbbb9、第5天SOFA评分不下降、需要有创机械通气是与院内死亡率相关的因素。ECOG、无法恢复抗癌治疗和因呼吸衰竭而入住ICU与住院幸存者的1年死亡率相关。结论:危重实体癌患者的生存率是可观的,即使存在转移性疾病。短期预后与ECOG和器官功能障碍有关,而与癌症本身无关。第5天SOFA评分不下降的患者预后较差,特别是第1天SOFA评分为bb90时。长期死亡率与功能状态和无法恢复抗癌治疗有关。
{"title":"Short- and long-term mortality in critically ill patients with solid cancer. The Vall d’Hebron Intensive Care Unit-Vall d’Hebron Institute of Oncology Cohort: a retrospective study","authors":"Cándido Díaz-Lagares ,&nbsp;Alejandra García-Roche ,&nbsp;Andrés Pacheco ,&nbsp;Javier Ros ,&nbsp;Erika P. Plata-Menchaca ,&nbsp;Adaia Albasanz ,&nbsp;David Pérez ,&nbsp;Nadia Saoudi ,&nbsp;Isabel Ruiz-Camps ,&nbsp;Elena Élez ,&nbsp;Ricard Ferrer","doi":"10.1016/j.medine.2025.502176","DOIUrl":"10.1016/j.medine.2025.502176","url":null,"abstract":"<div><h3>Objective</h3><div>To describe in-hospital and one-year mortality and to identify prognostic variables associated with mortality.</div></div><div><h3>Design</h3><div>Retrospective cohort study.</div></div><div><h3>Setting</h3><div>Tertiary referral hospital in Barcelona (Spain).</div></div><div><h3>Patients</h3><div><span>Consecutive patients with solid cancer and unplanned admission to the </span>ICU over a ten year period (2010–2019).</div></div><div><h3>Main variables of interest</h3><div><span><span><span>In-hospital mortality, one-year mortality, type of cancer, metastatic disease, </span>ECOG, APACHE, SOFA, invasive </span>mechanical ventilation, </span>vasoactive drugs<span>, renal replacement therapy.</span></div></div><div><h3>Results</h3><div><span>Three hundred and ninety-five patients were admitted to the ICU; 193 (48.8%) had metastatic disease, and 22 (5.9%) presented neutropenia. The median </span>SOFA score<span> on day 1 of ICU admission was 6 (3−9). ICU, in-hospital, and one-year mortality were 27.9% (110 patients), 39% (139 patients), and 61.1% (236 patients), respectively. A non-surgical admission, a higher ECOG, a SOFA score &gt; 9 on day 1, a non-decreasing SOFA score on day 5, and requiring invasive mechanical ventilation were factors associated with in-hospital mortality. ECOG, inability to resume anticancer therapy, and ICU admission due to respiratory failure were associated with one-year mortality in hospital survivors.</span></div></div><div><h3>Conclusion</h3><div>Survival in critically ill solid cancer patients is substantial, even when metastatic disease exists. Short-term outcomes were associated with ECOG and organ dysfunction, not cancer <em>per se</em><span>. The prognosis of patients with a non-decreasing SOFA score on day 5 is poor, especially when the SOFA score on day 1 was &gt;9. Long-term mortality was associated with functional status and inability to resume anticancer therapy.</span></div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502176"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143665801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of point-of-care ultrasonography in central venous catheter insertion: A randomized controlled trial of safety and cost-effectiveness 即时超声检查在中心静脉置管中的作用:一项安全性和成本效益的随机对照试验。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502221
Ahmed Beniamen , Ahmed Mosallem , Hossam Tharwat Ali , Hanaa A. Nofal , Essamedin M. Negm

Objective

The objective of the study was to compare landmark-based and ultrasound-guided techniques of central venous catheter insertion (CVC).

Design

Randomized controlled trial (2021–2023).

Setting

Zagazig University Hospitals (ZUH), a tertiary care center.

Patients

Adult patients in whom CVC insertion is indicated.

Main variables of interest

Demographic and clinical peri-procedural data, the safety of the technique, time of performance, and cost-effectiveness were compared.

Results

Patient ages ranged from 17 to 80 years with 56% being males. Urgent indications were found in around 22% without significant differences between groups. Regarding the time of performance, the ultrasound-guided method had slightly but significantly less time of performance (25.7 ± 4.3; range: 18−33) compared to the blind technique (26.9 ± 7.4; range: 15−45) (P-value < 0.001) with a higher but non-significant number of patients without complications (64% vs 52%; P-value = 0.2). Failure to insert the CVC into the IJV occurred in 12 patients (12%) with the blind technique and in eight patients (8%) with the ultrasound-guided technique (P-value = 0.04). Carotid artery puncture with neck hematoma occurred in only 8 (8%) patients with the blind technique (P-value = 0.04). Excess cost was consumed in only 36 patients (36%) in the blind technique group (P-value = 0.001).

Conclusion

Point-of-care ultrasonography bundle for CVC insertion is considered superior to, safer, and more cost-effective than the blind technique.
目的:本研究的目的是比较基于地标和超声引导的中心静脉置管技术(CVC)。设计:随机对照试验(2021-2023)。环境:扎加齐格大学医院(ZUH),三级护理中心。患者:指征CVC插入的成年患者。主要感兴趣的变量:人口统计学和临床围手术期数据,技术的安全性,执行时间和成本效益进行比较。结果:患者年龄从17岁到80岁不等,56%为男性。紧急适应症发生率约为22%,组间无显著差异。在表现时间方面,超声引导法的表现时间略短但显著(25.7 ± 4.3;范围:18-33)与盲法相比(26.9 ± 7.4;范围:15-45)(p值< 0.001),无并发症的患者数量较高但不显著(64% vs 52%;假定值 = 0.2)。盲法和超声引导法分别有12例(12%)和8例(8%)CVC插入失败(p值 = 0.04)。采用盲法穿刺颈动脉导致颈部血肿的患者仅8例(8%)(p值 = 0.04)。在盲法组中,只有36例(36%)患者消耗了额外的费用(p值 = 0.001)。结论:超声束在CVC插入中的应用优于盲法,安全性好,性价比高。
{"title":"The role of point-of-care ultrasonography in central venous catheter insertion: A randomized controlled trial of safety and cost-effectiveness","authors":"Ahmed Beniamen ,&nbsp;Ahmed Mosallem ,&nbsp;Hossam Tharwat Ali ,&nbsp;Hanaa A. Nofal ,&nbsp;Essamedin M. Negm","doi":"10.1016/j.medine.2025.502221","DOIUrl":"10.1016/j.medine.2025.502221","url":null,"abstract":"<div><h3>Objective</h3><div>The objective of the study was to compare landmark-based and ultrasound-guided techniques of central venous catheter insertion (CVC).</div></div><div><h3>Design</h3><div>Randomized controlled trial (2021–2023).</div></div><div><h3>Setting</h3><div>Zagazig University Hospitals (ZUH), a tertiary care center.</div></div><div><h3>Patients</h3><div>Adult patients in whom CVC insertion is indicated.</div></div><div><h3>Main variables of interest</h3><div>Demographic and clinical peri-procedural data, the safety of the technique, time of performance, and cost-effectiveness were compared.</div></div><div><h3>Results</h3><div>Patient ages ranged from 17 to 80 years with 56% being males. Urgent indications were found in around 22% without significant differences between groups. Regarding the time of performance, the ultrasound-guided method had slightly but significantly less time of performance (25.7 ± 4.3; range: 18−33) compared to the blind technique (26.9 ± 7.4; range: 15−45) (P-value &lt; 0.001) with a higher but non-significant number of patients without complications (64% vs 52%; P-value = 0.2). Failure to insert the CVC into the IJV<span> occurred in 12 patients (12%) with the blind technique and in eight patients (8%) with the ultrasound-guided technique (P-value = 0.04). Carotid artery puncture with neck hematoma occurred in only 8 (8%) patients with the blind technique (P-value = 0.04). Excess cost was consumed in only 36 patients (36%) in the blind technique group (P-value = 0.001).</span></div></div><div><h3>Conclusion</h3><div>Point-of-care ultrasonography bundle for CVC insertion is considered superior to, safer, and more cost-effective than the blind technique.</div></div>","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502221"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sedation and COVID-19. Time to forget, time for a comeback 镇静和COVID-19。是时候忘记了,是时候回归了。
Pub Date : 2025-11-01 DOI: 10.1016/j.medine.2025.502264
Sara Alcántara Carmona, Miguel Ángel Romera Ortega
{"title":"Sedation and COVID-19. Time to forget, time for a comeback","authors":"Sara Alcántara Carmona,&nbsp;Miguel Ángel Romera Ortega","doi":"10.1016/j.medine.2025.502264","DOIUrl":"10.1016/j.medine.2025.502264","url":null,"abstract":"","PeriodicalId":94139,"journal":{"name":"Medicina intensiva","volume":"49 11","pages":"Article 502264"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina intensiva
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1